Allergan Sales, LLC is recalling 72 bottles of Combigan (brimonidine tartrate/timolol maleate ophthalmic solution) 0.2%/0.5% because of deviations from Current Good Manufacturing Practice (cGMP) requirements. This prescription eye medication is used to lower pressure in the eyes for conditions like glaucoma. Because the manufacturing standards were not met, the safety and quality of the medication in this specific batch cannot be guaranteed. Consumers should check their bottles for the specific lot number listed below and contact their healthcare provider.
Manufacturing deviations indicate that the product was not produced under strictly controlled conditions, which could potentially lead to issues with the medication's potency, purity, or sterility. While no specific injuries were reported in this voluntary recall, using compromised ophthalmic solutions can pose a risk of irritation or ineffective treatment of eye pressure.
Healthcare provider consultation and pharmacy refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.